Treatment Options for ALS Patients

Treatment Options for ALS Patients

The solvable tragedy of Lou Gehrig’s disease: all 35,000 current ALS sufferers in the U.S. and 600,000 worldwide will soon die of their disease while existing therapeutics that might possibly help them remain out of reach unless we solve the barriers to access. Learn how one organization is restoring patients’…

#TBT – Former NFL Player Fights ALS

https://www.youtube.com/watch?v=FOlG2u68S7s In this Washington Post video, watch Kevin Turner, 45, who “played eight seasons at fullback with the New England Patriots and the Philadelphia Eagles. After being diagnosed with ALS in 2010, Turner has brought awareness to concussion-related issues in football as he continues to fight an incurable disease.”…

What is ALS and the Ice Bucket Challenge?

In this 2014 video, Mashable takes you back to the first edition of the Ice Bucket Challenge and how it took social media by storm. Mashable Explains takes a look at what ALS is and how it affects the body. Learn more about ALS: https://bit.ly/ALSNewsToday…

Amylyx Appoints Nobel Laureate Walter Gilbert to Board of Directors

Amylyx Pharmaceuticals, a company developing a innovative therapeutic for amyotrophic lateral sclerosis (ALS, or Lou Gehrig’s disease), recently announced that former Biogen CEO Walter Gilbert, Ph.D and Nobel Laureate, will join Amylyx’s board of directors. “Dr. Gilbert brings an enormous breadth of experience as a scientist, biotech founder,…

Documentary: Living with Motor Neurone Disease (MND)

Motor neurone disease (MND) is a terminal disease and is physically and emotionally devastating for both the sufferer and the carer. In this Tobin Brothers exclusive documentary, Lisa Morgan, wife of actor Richard Morgan, and former AFL coach Neale Daniher talked to Michael Lynch about their confronting experiences with…

In ALS Study, Essential Protein Seen as Promising New Theurapeutic Target

Researchers have identified an essential protein, Pur-alpha, for motor neuron cells’ mechanisms of defense against external stress and degeneration and also as a potential new therapeutic target for the treatment of amyotrophic lateral sclerosis (ALS, or Lou Gehrig’s disease). The research paper, “Pur-alpha regulates cytoplasmic stress granule dynamics and ameliorates…